Learning Objectives. Scope of the Problem 9/20/2012. By the end of the presentation the audience members will be able to:
|
|
- Calvin Hamilton
- 6 years ago
- Views:
Transcription
1 On Back Order RT Whiteman, Pharm.D Pharmacy Practice Resident St. Luke s Boise Medical Center Learning Objectives By the end of the presentation the audience members will be able to: Explain the most likely possible reasons for drug shortages in the United States Characterize the medications most affected in the shortage State the resources available that list and / or allow reporting of a drug shortage Scope of the Problem Currently, ASHP 1 lists over 200 drugs on shortage (not all are critical) Many are critical medications without alternative therapy Sterile injectable medications (~75%) Chemotherapy, anesthesia Many do not have a resolution date in sight Impact on Pharmacies 1. American Society of Health-System Pharmacists, Drug Shortages: Current Drugs. Available at: (August 31, 2012). 10. Kaakeh R, Sweet BV, et al. Impact of Drug shortages on U.S. Health Systems. Am J Health-Syst Pharm [Internet] Oct 1 [cited 2012 Aug 31]. 68: Available from: 1
2 The Real Problem A Scary Trend 2 2. Knox R. Shortages Lead Doctors to Ration Critical Drugs [Internet]. NPR; 2011 Oct 3 [cited 2012 Aug 31]. Available from What happened 2? 2. Knox R. Shortages Lead Doctors to Ration Critical Drugs [Internet]. NPR; 2011 Oct 3 [cited 2012 Aug 31]. Available from 2
3 Background Limited numbers of companies make the drugs that are currently in short supply Group Purchasing Organizations The market for these medications is behaving differently than other products in the free market Competing Theories Drug shortages CAUSED by the Food and Drug Administration (FDA) and other government programs / policies Assertion made by the Committee for Government Oversight and Reform, US house of representatives Oversight Committee 3 Few companies making drugs GPOs In 2010, 90% of generic injectable oncology drugs were produced by three or fewer manufacturers Overbearing FDA FDA effectively shut down 30% of drug production, spread over 4 companies Nearly 60% of drugs on shortage list were made by companies where production was affected by FDA remediation 3. U.S. House, Committee on Oversight and Government Reform. FDA s contribution to the Drug Shortage Crisis. Staff report 2012 Jun 15 (112 H). Available from: FDAs-Contribution-to-the-Drug-Shortage-Crisis.pdf 3
4 Oversight Committee Partly to blame: Medicare Modernization Act Interference with free market competition Prevention of price increase >6% Inelastic market pricing conditions 340(b) pricing Low prices, low margins Government Accountability Office 4 Analysis similar to Oversight Committee, but does not blame FDA for the problem Instead asserts that FDA needs to be strengthened to help with the crisis Mandatory reporting? Cites instances of prevented shortages 4. Crosse M. Drug Shortages: FDA s Ability to Respond Should be Strengthened. Statement before Committee on Health, Education, Labor, and Pensions, U.S. Senate Dec 15 [cited 2012 Aug 31]. Available from: Economics Price inelasticity on the demand side Mirrored on the supply side New generic approval From the manufacturer s perspective Why Increase production? Medicare Modernization Act ASPE DHHS Economic analysis of drug shortages - Kevin Haninger, Amber Jessup, and Kathleen Koehler of ASPE s Office of Science and Data Policy Oct. Available from 4
5 Executive order Basically the manifestation of GAO s recommendations Enforce adequate reporting of shortages Expedited regulatory review Review of certain behaviors by market participants 6. Obama B. Reducing Prescription Drug Shortages. Executive Order [Internet] Oct 31. Available from: FDA s Six-Month Checkup 7 States that the strongly encouraged voluntary reporting to FDA has resulted in prevention on many new drug shortages Importation of other drugs Prevention of propofol shortage? 7. Hamburg M. FDA Voice Six Month Check-Up: FDA s Work on Drug shortages [Internet]. U.S. Food and Drug Administration; 2012 May 3 [cited 2012 Aug 31]. Available from: Legislation Food and Drug Administration Safety and Innovation Act 8 Signed by the President July 9, 2012 Mandatory reporting of hiccups in manufacturing or plans to discontinue production Doesn t address gray market Problem solved! 8. Sullivan T. The Food and Drug Administration Safety and Innovation Act (FDASIA): Summary of GDUFA, MDUFA, BsUFA and Pediatrics [Internet] Jul 19 [cited 2012 Aug 31]. Available from: 5
6 The Gray Market Gray Market Also known as Secondary Purchasers Normal end-purchasers acquire medications, then sell small amounts to other end-purchasers at a large markup Not likely a cause of shortages Story-time! Gray Market Senate Committee on Commerce, Science, and Transportation Report 9 : The investigation has identified a number of businesses holding pharmacy licenses that appear to operate for the sole purpose of acquiring short-supply drugs that can be sold into the gray market What choice do we have? What are the consequences? 9. U.S. Senate, Committee on Commerce, Science, and Transportation. Shining light on the Gray market : An examination of why hospitals are forced to pay exorbitant prices for prescription drugs facing critical shortage. Staff report 2012 Jul 25 (112 S). Available from: ket.pdf 6
7 Shortages Really Cause Problems Tiny Triumphs - What is our Role? Report drug shortages ASHP FDA Report gray marketeers Problems with this Involvement with GPOs Outcomes Manufacturers are increasing production Slow process FDA is mediating Duct tape fix New normal? 7
8 Assessment Questions Which of the following is most likely NOT a reason for current drug shortages in the United States? A. Few manufacturers making critical drugs B. Grey Market scalpers C. Compromised manufacturing processes under updates D. Price Inelasticity in the drug market Assessment Questions Which of the following medications is most likely to be affected by the shortage? A. Normal Saline 1000ml IV bags B. Seroquel XR 100mg tablets C. Danorubicin Hydrochloride injection D. Omeprazole 20mg OTC tablets Assessment Questions Which of the following groups give online access to report / list current drug shortages A. ASHP.org B. FDA.gov C. Tevapharm.com D. Both A and B 8
9 References 1. American Society of Health-System Pharmacists, Drug Shortages: Current Drugs. Available at: (August 31, 2012). 2. Knox R. Shortages Lead Doctors to Ration Critical Drugs [Internet]. NPR; 2011 Oct 3 [cited 2012 Aug 31]. Available from 3. U.S. House, Committee on Oversight and Government Reform. FDA s contribution to the Drug Shortage Crisis. Staff report 2012 Jun 15 (112 H). Available from: 4. Crosse M. Drug Shortages: FDA s Ability to Respond Should be Strengthened. Statement before Committee on Health, Education, Labor, and Pensions, U.S. Senate Dec 15 [cited 2012 Aug 31]. Available from: 5. ASPE DHHS Economic analysis of drug shortages - Kevin Haninger, Amber Jessup, and Kathleen Koehler of ASPE s Office of Science and Data Policy Oct. Available from 6. Obama B. Reducing Prescription Drug Shortages. Executive Order [Internet] Oct 31. Available from: 7. Hamburg M. FDA Voice Six Month Check-Up: FDA s Work on Drug shortages [Internet]. U.S. Food and Drug Administration; 2012 May 3 [cited 2012 Aug 31]. Available from: 8. Sullivan T. The Food and Drug Administration Safety and Innovation Act (FDASIA): Summary of GDUFA, MDUFA, BsUFA and Pediatrics [Internet] Jul 19 [cited 2012 Aug 31]. Available from: 9. U.S. Senate, Committee on Commerce, Science, and Transportation. Shining light on the Gray market : An examination of why hospitals are forced to pay exorbitant prices for prescription drugs facing critical shortage. Staff report 2012 Jul 25 (112 S). Available from: on%20the%20gray%20market.pdf 10. KaakehR, Sweet BV, et al. Impact of Drug shortages on U.S. Health Systems. Am J Health-Syst Pharm [Internet] Oct 1 [cited 2012 Aug 31]. 68: Available from: 9
A shortage of everything except ERRORS
Disclosure Succinylcholine Propofol Vitamin K Lorazepam Diltiazem Drug Shortages Current Status & State Survey Results Bill Stevenson Director of Pharmacy Oconee Medical Center I do not have a vested interest
More informationParenteral Nutrition Drug Shortages
Parenteral Nutrition Drug Shortages Deborah R. Houston, BS, Pharm.D, BCNSP A.S.P.E.N. Clinical Practice Committee Member Pharmacy Clinical Program Coordinator Advanced Home Care High Point, North Carolina
More informationEVALUATION OF THE FINANCIAL IMPACT OF MEDICATION BACKORDERS IN A TERTIARY CARE HOSPITAL. Kalyn Marie Acker
EVALUATION OF THE FINANCIAL IMPACT OF MEDICATION BACKORDERS IN A TERTIARY CARE HOSPITAL by Kalyn Marie Acker PharmD, University of Texas at Austin, 2015 BS in Biochemistry, Texas Tech University, 2011
More information40. What Are the Ethical Issues with Drug Shortages in the ICU? Steven E. Pass, PharmD, FCCM, FCCP, BCPS
40. What Are the Ethical Issues with Drug Shortages in the ICU? Steven E. Pass, PharmD, FCCM, FCCP, BCPS Drug product shortages are a significant and increasing concern for critical care practitioners.
More informationThe National Drug Shortage inems. Objectives 12/18/2012. Who regulates what? How do they potentially impact EMS?
The National Drug Shortage inems Brent Myers, MD, MPH Sabina Braithwaite, MD, MPH Objectives Describe what factors are contributing to the drug shortage List recent advocacy efforts pertinent to the drug
More informationPosition Statement on Prescription Drug Shortages in Canada
CMA POLICY Position Statement on Prescription Drug Shortages in Canada The escalation in shortages of prescription drugs in the past few years and the ongoing disruptions to supply experienced in Canada
More informationFDA Reauthorization Act of 2017 (FDARA)
FDA Reauthorization Act of 2017 (FDARA) April 4, 2018 PRESENTED BY: Jessica Ringel Counsel FDA & Life Sciences Practice Group King & Spalding LLP (202) 626-9259 jringel@kslaw.com FDA Reauthorization Act
More informationDrug Shortages. March 29, Submitted by:
CMA s Submission to the House of Commons Standing Committee on Health: Drug Shortages March 29, 2012 Submitted by: John Haggie, MB, ChB, MD, FRCS President A healthy population and a vibrant medical profession
More informationDrug Shortage Preparedness
PURDUE UNIVERSITY COLLEGE OF PHARMACY S CENTER FOR MEDICATION SAFETY ADVANCEMENT Drug Shortage Preparedness Survey and Tips for Improvement Developed by: Jonathan Weir, PharmD Candidate in collaboration
More informationDrug shortage management in Alabama hospital pharmacies Oliver W. Holmes III, Pharm.D. Candidate 2013; Peter J. Hughes, Pharm.D.
Drug shortage management in Alabama hospital pharmacies Oliver W. Holmes III, Pharm.D. Candidate 2013; Peter J. Hughes, Pharm.D., BCPS Key words: drug shortage, pharmacy, hospital, Alabama Abstract Purpose:
More informationAdministrative Update: How to Implement Discharge Pharmacy Services (DPS) Objectives
Administrative Update: How to Implement Discharge Pharmacy Services (DPS) Morgan Pendleton, PharmD, BCOP Hematology/Oncology Clinical Pharmacist Wake Forest Baptist Health Objectives Evaluate the need
More informationDecember 21, 2012 BY ELECTRONIC DELIVERY
BY ELECTRONIC DELIVERY CDR Krista M. Pedley, PharmD, MS, USPHS Director Office of Pharmacy Affairs Healthcare Systems Bureau Health Resources and Services Administration 5600 Fishers Lane Parklawn Building,
More informationD2: Technician: Drug Shortages: An Unprecedented Na onal Impediment of Pa ent Care and Safety 1:45pm - 2:45pm
February 8-10, 2013 The Meadows Events & Conference Center Altoona, Iowa D2: Technician: Drug Shortages: An Unprecedented Na onal Impediment of Pa ent Care and Safety 1:45pm - 2:45pm ACPE UAN 107-000-13-019-L05-T
More information3/16/2017. A Tale of Two Specialty Pharmacies: Novel Models for Technician Incorporation. Objectives. What is Specialty Pharmacy?
A Tale of Two Specialty Pharmacies: Novel Models for Technician Incorporation Disclosures The speakers have no actual or potential conflict of interest to the content of this presentation. Renee Advincula,
More informationFormulary Hot Topics Panel Discussion
Formulary Hot Topics Panel Discussion Ohio Society of Health System Pharmacists 77 th Annual Meeting FRIDAY, April 22, 2016 8:30-9:30 AM Bexley Ballroom II Panel Speakers & Case Facilitators Mandy Leonard,
More informationPharmacy Management. 450 Pharmacy Management Positions
450 Pharmacy Management Positions Pharmacy Management Disposition of Illicit Substances (1522) To advocate that healthcare organizations be required to develop procedures for the disposition of illicit
More informationAbout Baptist Medical Center
About Baptist Medical Center Locally owned and operated in Jacksonville, Florida BMC includes 2 Adult and 1 Children s Hospital 960 licensed beds Disproportionate Share Hospital Recently opened Baptist
More informationInteractive Review for Medical Device Submissions: 510(k)s, Original PMAs, PMA Supplements, Original BLAs, and BLA Supplements
Guidance for Industry and FDA Staff Interactive Review for Medical Device Submissions: 510(k)s, Original PMAs, PMA Supplements, Original BLAs, and BLA Supplements Document Issued on: February 28, 2008
More information4/18/2018. Improving USP <800> Compliance in a Community Healthcare Organization. Disclosures. Learning Objectives
Improving USP Compliance in a Community Healthcare Organization Brady Conner, Pharm.D. PGY1 Pharmacy Resident St. Vincent Healthcare, Billings, MT 4/20/1018 Disclosures IRB Status: Exempt Co-investigators
More informationPharmacy inventory specialists will work directly with the wholesaler in the event that product is needed for emergency shipment.
Drug Shortages Affecting MHMH and Action Plans for Specific Shortages Drug Shortage information Action Plan Adenosine inj Pharmacy is unable to obtain the vials currently stocked on the emergency carts
More informationLeveraging your own health plan to build a Specialty Pharmacy
Leveraging your own health plan to build a Specialty Pharmacy Brad Trom, RPH, MBA, CEO Lovelace Pharmacy, Lovelace Health System, Albuquerque, New Mexico Disclosure Brad Trom reports no relevant financial
More informationDecreasing the Unplanned Readmission Rate of Patients receiving Outpatient Antibiotic Therapy(OPAT)
Decreasing the Unplanned Readmission Rate of Patients receiving Outpatient Antibiotic Therapy(OPAT) Dr. Jose Cadena Dr. Amruta Parekh University of Texas Health Science Center at San Antonio San Antonio,
More informationNEW JERSEY. Downloaded January 2011
NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if
More informationCommunity Pharmacy in 2016/17 and beyond
Community Pharmacy in 2016/17 and beyond Stakeholder briefing sessions 1 CONTENTS Contents This presentation describes our vision for community pharmacy, and outlines proposals for achieving that vision,
More informationUniversity of Mississippi Medical Center University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation
University of Mississippi Medical Center University of Mississippi Health Care Pharmacy and Therapeutics Committee Medication Use Evaluation TJC Standards for Medication Management March 2012 Purpose The
More informationAntimicrobial Stewardship Program in the Nursing Home
Antimicrobial Stewardship Program in the Nursing Home CAHF San Bernardino/Riverside Chapter May 19 th, 2016 Presented by Robert Jackson, Pharm.D. Pharmaceutical Consultant II, Specialist CDPH Licensing
More informationImplementation of Remote Management of Compounded Sterile Products through the use of a Telepharmacy System
Implementation of Remote Management of Compounded Sterile Products through the use of a Telepharmacy System Jerry Siegel Pharm.D., FASHP Howard Cohen M.S.,RPh FASHP Marianne Ivey Pharm.D., FASHP Safe Medication
More informationFood Safety Modernization Act (FSMA)
Food Safety Modernization Act (FSMA) FDA FSMA Timeline July 29, 2009 House version passed Votes 283-142 Nov. 30, 2010 Senate version passed Votes 73-25 Dec. 19, 2010 Senate revised version passed Unanimous
More informationCDER Small Business and Industry Assistance (SBIA)
CDER Small Business and Industry Assistance (SBIA) Brenda Stodart, PharmD, BCGP Director CDER Small Business and Industry Assistance (SBIA) Division of Drug Information (DDI) Center for Drug Evaluation
More informationCreating the future. Celebrating the past. Learning Objectives. Disclosure. How Provider Status, PAI, and YOU Can Impact the Future of Pharmacy
Creating the Future How Provider Status, PAI, and YOU Can Impact the Future of Pharmacy Aretha Hankinson, J.D. Director, Advocacy Communications ASHP Learning Objectives Identify the steps that the profession
More informationUS Compounding 2515 College Ave Conway, AR (800)
PCAB Compounding Accreditation Accreditation Summary US Compounding 2515 College Ave Conway, AR 72034 (800) 718 3588 www.uscompounding.com Date of Last In-Pharmacy Survey: June 2008 Next Scheduled In-Pharmacy
More informationTaking Into Account Entire Supply Chain. Biopharmaceutical Companies
340B 101 Taking Into Account Entire Supply Chain Biopharmaceutical Companies Providers Payers and PBMs 2 Medicine Spending is in Line with Other Health Care Services Percent Annual Growth Rate Health Care
More informationGuide to reporting drug shortages and discontinuations GUI-0120
Guide to reporting drug shortages and discontinuations GUI-0120 March 14, 2017 Guide to reporting drug shortages and discontinuations (GUI-0120) Author: Health Products Compliance Directorate Date issued:
More informationDC Board of Pharmacy and Pharmaceutical Control Update
DC Board of Pharmacy and Pharmaceutical Control Update Patricia M. D Antonio, RPh, MS, MBA,CGP Executive Director, Board of Pharmacy Program Manager, Pharmaceutical Control May 30, 2015 Organization Health
More information11/4/2016. Sterile Compounding: USP<797> Revisions and the Compounding Quality Act. In the 1930 s and 40 s, 60% of all medications were compounded.
Sterile : USP Revisions and the Quality Act Joe Haynes, RPh, CPh, MBA Lead Sterile Products Pharmacist Johns Hopkins All Children s Hospital Objectives: Disclosure: I have no financial interests to
More informationMarketing. Pharmaceutical Industry: Marketing Positions 445
Marketing Pharmaceutical Industry: Marketing Positions 445 Restricted Drug Distribution (1714) To oppose restricted drug distribution systems that (1) limit patient access to medications; (2) undermine
More informationDefinitions: In this chapter, unless the context or subject matter otherwise requires:
CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable
More informationHospitals and the Economy. Anne McLeod Vice President, Finance Policy California Hospital Association
Anne McLeod Vice President, Finance Policy California Hospital Association American hospitals are financially challenged and the trends in revenues and expenses will put and even greater burden on the
More informationA competent pharmacy technician workforce will be fundamental to advancing the patient care role of
CPE Information and Disclosures Advancing the Roles for Pharmacy Technicians in an Evolving Health Care Environment: Failure is Not an Option! Michigan Pharmacists Association February 25, 2017 Miriam
More informationEVIDENCE-BASED REVIEW PROCESS FOR FORMULARY DRUG ADDITION
EVIDENCE-BASED REVIEW PROCESS FOR FORMULARY DRUG ADDITION HAJER Y. AL MUDAIHEEM, PHARMD. MS CLINICAL PHARMACY HEAD, NATIONAL DRUG INFORMATION CENTER GENERAL PHARMACEUTICAL CARE DEPARTMENT HALMUDAIHEEM2MOH.GOV.SA
More informationERIC CROPP PERSONAL BACKGROUND
Page 1 Emily's Act: Impact on Public Safety and Medication Errors Eric Cropp, RPh Kevin McCarthy, RPh This program has been brought to you by PharmCon PharmCon is accredited by the Accreditation Council
More informationStatement of Ronna B. Hauser, Pharm.D. Vice President, Policy and Regulatory Affairs National Community Pharmacists Association
Statement of Ronna B. Hauser, Pharm.D. Vice President, Policy and Regulatory Affairs National Community Pharmacists Association Food and Drug Administration [Docket Nos. FDA 2010 N 0284 and FDA 2009 D
More informationPCAB Compounding Accreditation Accreditation Summary
PCAB Compounding Accreditation Accreditation Summary McGuff Compounding Pharmacy Services, Inc Santa Ana, California compounding pharmacy 2921 W. MacArthur Blvd., Ste.142 Santa Ana, CA 92704 Telephone:877-444-1133
More informationIntroduction to Pharmacy Practice
Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians
More informationAvailable through Medicis for active cases only. Will be sent overnight if needed. Call
Drug Reason for Shortage Action Plan Merck has low inventory of Antivenin Latrodectus Mactans Black Widow Antivenin Calcium chloride and calcium gluconate Calcium Disodium Versenate Change in distribution
More informationFrom Implementation to Optimization: Moving Beyond Operations
From Implementation to Optimization: Moving Beyond Operations Session 260, March 8, 2018 Scott Aikey, Sr. Director, Core Clinical Applications Children s Hospital of Philadelphia 1 Conflict of Interest
More informationASHP Guidelines on Evaluating and Using Home or Alternate-Site Infusion Service Providers
Practice Settings Guidelines 515 ASHP Guidelines on Evaluating and Using Home or Alternate-Site Infusion Service Providers These guidelines describe the roles of home or alternatesite infusion service
More informationFDA SEATTLE DISTRICT REGULATORY UPDATE
FDA SEATTLE DISTRICT REGULATORY UPDATE SEAFOOD PRODUCTS ASSOCIATION PROCESSORS WORKSHOP SEATTLE, WASHINGTON MARCH 10, 2015 MIRIAM R. BURBACH SEATTLE DISTRICT DIRECTOR 1 FDA SEATTLE DISTRICT REGULATORY
More informationQuality Management Report 2017 Q2
Quality Management Report 2017 Q2 Quality Management Program CMS STAR Ratings Member Satisfaction (CAHPS & HOS) HEDIS Risk Adjustment DHS Member Incident Reporting Member Satisfaction Surveys Pay for Performance
More informationCHAPTER 19 THE FORMULARY SYSTEM
CHAPTER 19 THE FORMULARY SYSTEM 19.1 Formulary System In the Nursing Home I. OTC Formulary for Medicaid Residents (Patient Care Formulary) 1. OTC medications must be available for Medicaid residents. 2.
More informationA Million Little Pieces: Developing a Controlled Substance Diversion Program. Tanya Y. Barnhart, PharmD, BCPS
A Million Little Pieces: Developing a Controlled Substance Diversion Program Tanya Y. Barnhart, PharmD, BCPS I have no conflicts of interest to disclose Objectives Explain the importance of building a
More informationObjectives. Hospital Pharmacy Strategies for REMS. Evolution of FDA Drug Safety Programs. REMS: Definition. Evolution of FDA Drug Safety Programs
Objectives Hospital Pharmacy Strategies for REMS SCSHP Fall Meeting October 28, 2010 John Pearson, PharmD, BCNSP, BCPS Manager, Pharmacy Clinical Services Greenville Hospital System University Medical
More informationASHP UPDATE. The Path to Provider Status. Disclosure. Learning Objectives. Learning Objectives 2/18/2018. The Intersection of Healthcare & Policy
Disclosure ASHP UPDATE The presenter for this continuing education activity reports no relevant financial relationships No off-label uses of medications will be described in this presentation Thomas J.
More informationNORTH CAROLINA. Downloaded January 2011
NORTH CAROLINA Downloaded January 2011 10A NCAC 13D.2306 MEDICATION ADMINISTRATION (a) The facility shall ensure that medications are administered in accordance with standards of professional practice
More informationRita Shane, Pharm.D., FASHP, FCSHP Chief Pharmacy Officer Cedars-Sinai Medical Center Asst. Dean, Clinical Pharmacy, UCSF School of Pharmacy
Rita Shane, Pharm.D., FASHP, FCSHP Chief Pharmacy Officer Cedars-Sinai Medical Center Asst. Dean, Clinical Pharmacy, UCSF School of Pharmacy Describe the transformation of health-systems in response to
More informationFollowing are some common questions and answers from the hospital perspective regarding Manufacturing and Compounding :
Health Canada Manufacturing and Compounding Drug Products in Canada: A Policy Framework : Guidelines for P.E.I. Community and Hospital Pharmacists October 2001 In response to pharmacists questions about
More informationCompounded Sterile Preparations Pharmacy Content Outline May 2018
Compounded Sterile Preparations Pharmacy Content Outline May 2018 The following domains, tasks, and knowledge statements were identified and validated through a role delineation study. The proportion of
More informationSolve the most challenging problems in practice Learn an evidence-based problem-solving approach
2015 Curriculum Builds strengths that prepares graduates for career success Become a collaborate healthcare team member As the team s pharmacist, you will be respected for your contributions to patient
More informationCanada s Multi-Stakeholder Approach to Drug Shortages
Canada s Multi-Stakeholder Approach to Drug Shortages Health Canada Presentation to the Canadian Agency For Drugs And Technologies In Health April X, 2017 Overview Context A Collaborative Multi-Stakeholder
More informationBlack Widow Antivenin
Drug Shortage information Action Plan Merck has low inventory of Antivenin Latrodectus Mactans. The company cannot estimate when regular distribution will resume. Merck announced that the expiration date
More informationOmnibus Budget Reconciliation Act of 1990 and 1993
Omnibus Budget Reconciliation Act of 1990 and 1993 Pantea Ghasemi, USC Pharm.D. Candidate of 2015 Sarkis Kavarian, UOP Pharm.D. Candidate of 2015 Preceptor Dr. Craig Stern Pro Pharma Pharmaceutical Consultants,
More informationThe Pharmacy Profession in Minnesota 2013 Marilyn K. Speedie, Ph.D., Dean University of Minnesota College of Pharmacy
The Pharmacy Profession in Minnesota 2013 Marilyn K. Speedie, Ph.D., Dean University of Minnesota College of Pharmacy Over the past 20 years, drug therapy has become more complex: More medications per
More informationRe: 42 CFR Part 485; Medicare Program; Conditions of Participation (CoPs) for Community Mental Health Centers
August 12, 2011 Centers for Medicare & Medicaid Services Department of Health and Human Services P.O. Box 8013 Baltimore, MD 21244-8013 Re: 42 CFR Part 485; Medicare Program; Conditions of Participation
More informationFrom 2009 to 2012, the total change in net operating revenue among all hospitals was 3.3%, with an average annual change of 1.1%.
Market Insights For the Health of Your Health System January 2014 Issue 6 Inside This Issue Healthcare Snapshot Public Policy Perspectives Financial Focus Supply Chain Strategies A Closer Look Specialty
More informationCritical Access Hospitals Site Visit Summary Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital
Critical Access Hospitals Site Visit Summary 2014 2015 Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital 2014 2015 13 Critical Access Hospitals (CAH) Site Visits Compounded
More informationEvolving Roles of Pharmacists: Integrating Medication Management Services
Evolving Roles of Pharmacists: Integrating Management Services Marie Smith, PharmD, FNAP Palmer Professor and Assistant Dean, Practice and Policy Partnerships UCONN School of Pharmacy (marie.smith@uconn.edu)
More information4/26/2017. Emergency Department Pharmacist Interventions in a Small, Rural Hospital. Disclosure Statement. Learning Objectives
Emergency Department Pharmacist Interventions in a Small, Rural Hospital Chaundra Sewell, PharmD PGY1 Pharmacy Practice Resident Community Medical Center Missoula, MT Disclosure Statement This presenter
More informationPharmacovigilance & Managed Care Pharmacy. Issues for Medication Safety in Korea
Pharmacovigilance and Managed Care Pharmacy Issues for Medication Safety in Korea Hyun Taek Shin, Pharm.D. Professor, College of Pharmacy Sookmyung University & President, Korean Academy of Managed Care
More informationAssociation of Cancer Executives
Association of Cancer Executives 340B Drug Pricing Program How to Get It and Make the Most of It January 31, 2014 ECG Management Consultants, Inc. Our mission is to provide exceptional management consulting
More informationThe FDA Medical Device User Fee Program
Judith A. Johnson Specialist in Biomedical Policy June 25, 2012 CRS Report for Congress Prepared for Members and Committees of Congress Congressional Research Service 7-5700 www.crs.gov R42508 Summary
More informationSuccessfully maintaining a formulary that represents
in a Large, Multihospital System Laura BeQuette, PharmD; Joseph K. Jordan, PharmD, BCPS; Amy Heck Sheehan, PharmD; and James A. Jorgenson, MS, RPh At a Glance Practical Implications p 320 Author Information
More informationContext. Objectives. Hospital-based Pharmacy and Therapeutics Committees: Evolving Responsibilities and Membership
Issue 23 July 2011 Hospital-based Pharmacy and Therapeutics Committees: Evolving Responsibilities and Membership Context In this report, the term Pharmacy and Therapeutics Committee () refers to a committee
More informationPPI Deprescribing: Ascension
PPI Deprescribing: Ascension Tonya Thomas, PharmD Clinical Pharmacist Saint Thomas West Hospital Nashville, TN, USA #derx2018 Session resources will be available at deprescribing.org/resources Learning
More informationUnderstanding the Pharmacy and Drug Act amendments and mail order pharmacy licensing
Understanding the Pharmacy and Drug Act amendments and mail order pharmacy licensing Background As reported in the Spring 2009 issue of acpnews, ACP and Alberta Health and Wellness developed a new policy
More informationFederal Legislation to Address the Opioid Crisis: Medicaid Provisions in the SUPPORT Act
October 2018 Issue Brief Federal Legislation to Address the Opioid Crisis: Medicaid Provisions in the SUPPORT Act MaryBeth Musumeci and Jennifer Tolbert On October 3, 2018, the Senate overwhelmingly passed
More informationExpanding Access to Financing & Telehealth for Rural Health Care Providers: Washington State
Expanding Access to Financing & Telehealth for Rural Health Care Providers: Washington State September 13, 2016 in Olympia, Washington September 15, 2016 in Cheney, Washington Leila Samy, MPH Rural Health
More informationFalls Prevention in Hospital: Development of a novel decision support medication stewardship application
Innovation Partnership Procurement by Co-Design Falls Prevention in Hospital: Development of a novel decision support medication stewardship application Challenge Brief Contact name Response deadline Calvin
More informationTHE BASICS THE BASICS STAFF EDUCATION DRUG DIVERSION TASK FORCE 4/8/2016. MSHP Annual Meeting 2016
/8/01 MSHP Annual Meeting 01 DEA Audit and Investigation Lessons Learned: Training, Reporting, Surveillance, Auditing and Technology Erasmo (Ray) Mitrano, RPh, MS, Senior Director Controlled Substance
More informationAmbulatory Care Clinical Management
Ambulatory Care Clinical Management PGY2 - Health-System Pharmacy Administration (87405) Faculty: Berrett, Golden B.; Tyler, Linda S. Site: University of Utah Hospitals Clinics Status: Active Required
More informationJun 03 Jul 03 Aug 03 Sep 03 Oct 03 Nov 03 Dec 03 Jan 04 Feb 04 Mar 04 Apr 04 May 04
7000 6000 5000 4000 Power 01 Jun 04 Goal Planned 3000 2000 3193 3236 3263 3543 3948 3582 3452 Jun 03 Jul 03 Aug 03 Sep 03 Oct 03 Nov 03 Dec 03 Jan 04 Feb 04 Mar 04 Apr 04 May 04 Electrical Generation Pre-War
More informationWhat is MTM? Objectives. MTM: Successfully Engaging Eligible Patients. What is MTM? MTM Background. MTM Examples 09/11/2012
MTM: Successfully Engaging Eligible Patients Objectives Explain What MTM is as defined by the Medicare Modernization Act Describe examples of MTM services Recognize the various entities who pay for MTM
More informationOriginal Research PRACTICE-BASED RESEARCH. University Wexner Medical Center
Evaluation of provider documentation of medication management in a Patient-Centered Medical Home (PCMH) Trang T. Nguyen, PharmD 1 ; Bella H Mehta, PharmD, FAPhA 2 ; Jennifer L. Rodis, PharmD, BCPS 2 ;
More information2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question. Disclosures. Learning Objectives 3/16/2017
2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question Nicole Allcock, PharmD, BCPS, FASHP Noelle RM Chapman, PharmD, BCPS, FASHP Joel Hennenfent, PharmD, MBA, BCPS, FASHP Jen
More informationCOLLABORATIVE PRACTICE SUCCESSES IN PRIMARY CARE
COLLABORATIVE PRACTICE SUCCESSES IN PRIMARY CARE KPhA Annual Meeting September 7, 2014 Tiffany R. Shin, PharmD, BCACP Lyndsey N. Hogg, PharmD, BCACP Objectives Describe basic concepts of collaborative
More informationSpecialty Pharmacy How is Traditional Pharmacy Practice Positioned
Specialty Pharmacy How is Traditional Pharmacy Practice Positioned Nick Calla Vice President, Industry Relations Cardinal Health Specialty Solutions August 19, 2016 Today s Learning Objectives Understand
More information41 USC NB: This unofficial compilation of the U.S. Code is current as of Jan. 4, 2012 (see
TITLE 41 - PUBLIC CONTRACTS Subtitle I - Federal Procurement Policy Division B - Office of Federal Procurement Policy CHAPTER 17 - AGENCY RESPONSIBILITIES AND PROCEDURES 1703. Acquisition workforce (a)
More informationPositioning Remotely Delivered Pharmacist Care in Small and Rural Settings
Positioning Remotely Delivered Pharmacist Care in Small and Rural Settings Kelly Morrison Director of Remote Pharmacy Services Cardinal Health Richard Stomackin, BS. Pharm Director of Pharmacy Geisinger
More informationDisclosures. Objectives. Leveraging and Developing Your Team for Optimal Outcomes. None
Leveraging and Developing Your Team for Optimal Outcomes Michelle W. McCarthy, PharmD, FASHP Coordinator, Pharmacy Education and Graduate Programs Charlottesville, VA November 6, 2017 Disclosures None
More informationBackground and Methodology
Study Sites and Investigators Emergency Department Pharmacists Improve Patient Safety: Results of a Multicenter Study Supported by the ASHP Foundation Jeffrey Rothschild, MD, MPH-Principal Investigator
More informationENRICHING THE POLICY-MAKING PROCESS THROUGH MULTISTAKEHOLDER DIALOGUE
ENRICHING THE POLICY-MAKING PROCESS THROUGH MULTISTAKEHOLDER DIALOGUE WHO BI-REGIONAL CONSULTATION ON GOOD GOVERNANCE FOR IMPROVED ACCESS TO MEDICINES 9 Nov 2015 Manila Philippines 1 INTRODUCTION MeTA:
More informationMedication Assisted Treatment for Opioid Use Disorders Reporting Requirements
This document is scheduled to be published in the Federal Register on 09/27/2016 and available online at https://federalregister.gov/d/2016-23277, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES
More informationReprinted from FDA s website by
Reprinted from FDA s website by POLICY AND PROCEDURES PURPOSE OFFICE OF EXECUTIVE PROGRAMS Accreditation -- Continuing Education Table of Contents PURPOSE...1 BACKGROUND...1 POLICY...3 RESPONSIBILITIES...7
More informationIMPROVED PATIENT OUTCOMES AND FINANCIAL PERFORMANCE THE VALUE OF INTEGRATED OUTSOURCED SERVICES SUPPORTING RARE DISEASE PHARMACEUTICAL COMPANIES.
IMPROVED PATIENT OUTCOMES AND FINANCIAL PERFORMANCE THE VALUE OF INTEGRATED OUTSOURCED SERVICES SUPPORTING RARE DISEASE PHARMACEUTICAL COMPANIES. By 2020, the global cost of orphan drugs is expected to
More informationOCTOBER IS AMERICAN PHARMACISTS MONTH. American Pharmacists Month. Planning Guide
American Pharmacists Month Planning Guide O V E R V I E W How will you celebrate? Discover Activities for Your Practice Setting! American Pharmacists Month is a golden opportunity to celebrate the pharmacy
More informationRURAL SWING BED MANAGEMENT (RSBM) TRAINING PROGRAM
RURAL SWING BED MANAGEMENT (RSBM) The Georgia State Office of Rural Health and HOMETOWN HEALTH Present: The Need for Rural Swing Bed Training One of the challenges that rural hospitals face today is a
More informationPharmacists Improve Care Through Team Collaboration
Pharmacists Improve Care Through Team Collaboration Trista Pfeiffenberger, PharmD, MS Director, Network Pharmacy Programs Community Care of North Carolina Disclosure and Conflict of Interest I am an employee
More informationOVERVIEW OF STATEMENT OF MICHAEL MARCHLIK VICE PRESIDENT - QUALITY ASSURANCE AND REGULATORY AFFAIRS MCKESSON TECHNOLOGY SOLUTIONS
OVERVIEW OF STATEMENT OF MICHAEL MARCHLIK VICE PRESIDENT - QUALITY ASSURANCE AND REGULATORY AFFAIRS MCKESSON TECHNOLOGY SOLUTIONS McKesson supports HR 3303, the Sensible Oversight for Technology Which
More informationState-Level Data Collection: Allied Health Workforce Planning in North Carolina
State-Level Data Collection: Allied Health Workforce Planning in North Carolina Erin Fraher, PhD MPP Director, North Carolina Health Professions Data System Presentation to the IOM Allied Health Workforce
More informationCompliance Division Staff Report
Compliance Division Staff Report Polygraph Advisory Board Meeting Tuesday, September 26, 2017 Public Outreach Compliance Division routinely attends annual industry meetings held by TALEPI (Texas Association
More informationManaging Pharmaceuticals to Reduce Medication Errors August 26, 2003
Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003 Susan M. Proulx, Pharm.D. President, Med-E.R.R.S. Subsidiary of ISMP (www.med-errs.com) Mission of ISMP Translate errors into education
More information